Mark Allegretta

2.4k citations

32 papers · 1.9k indexed · h-index 20

Immunology top 2%
Molecular Biology
Pathology and Forensic Medicine top 5%
Oncology top 10%
Radiology, Nuclear Medicine and Imaging top 5%

Co-authors: Richard J. Albertini Janice A. Nicklas Subramaniam Sriram Roy A. Dempsey Lawrence Steinman David Parkinson Stefan Brocke Dennis J. Mitchell
Topics: T-cell and B-cell Immunology (8 papers)Immune Cell Function and Interaction (7 papers)CAR-T cell therapy research (5 papers)
Cited by: Immunology Hepatology Pathology and Forensic Medicine
Journals: Nature Science Journal of Clinical Investigation
Partner nations: United States Canada France

In The Last Decade

Mark Allegretta

32 papers receiving 1.8k citations

Peers

Countries citing papers authored by Mark Allegretta

Since Specialization

Citations

This map shows the geographic impact of Mark Allegretta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Allegretta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Allegretta more than expected).

Fields of papers citing papers by Mark Allegretta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Allegretta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Allegretta. The network helps show where Mark Allegretta may publish in the future.

Co-authorship network of co-authors of Mark Allegretta

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Allegretta. A scholar is included among the top collaborators of Mark Allegretta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Allegretta. Mark Allegretta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pathways to cures for multiple sclerosis: A research roadmap 2022 ·Multiple Sclerosis Journal ·Bruce F. Bebo,Mark Allegretta,Douglas Landsman,Kathleen M. Zackowski,Fiona Brabazon,Walter A. Kostich,Timothy Coetzee,Alexander V. Ng,Ruth Ann Marrie,Kelly R. Monk,Amit Bar‐Or,Caroline C. Whitacre	16
2	Serum neurofilament light as a biomarker in progressive multiple sclerosis 2020 ·Neurology ·Raju Kapoor,(unknown),Mark Allegretta,Douglas L. Arnold,William M. Carroll,Manuel Comabella,Roberto Furlan,Christopher Harp,Jens Kühle,David Leppert,Tatiana Plavina,Finn Sellebjerg,(unknown),Charlotte E. Teunissen,(unknown),Florian von Raison,(unknown),Robert J. Fox	108
3	Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma 2011 ·Anti-Cancer Agents in Medicinal Chemistry ·Mark Allegretta,Jorge Filmus	26
4	Glypican-3 immunocytochemistry in liver fine-needle aspirates 2007 ·Cancer ·Dina Kandil,Gladwyn Leiman,Mark Allegretta,Winifred Trotman,Liron Pantanowitz,Robert A. Goulart,Mark Evans	88
5	Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas 2006 ·Human Pathology ·Xianhuo Wang,(unknown),Sylvie Dubois,(unknown),Mark Allegretta,Ronald D. Guttmann,S Jothy,Jacques Belghiti,Pierre Bédossa,Valérie Paradis	175
6	HPRT mutations, TCR gene rearrangements, and HTLV‐1 integration sites define in vivo T‐cell clonal lineages 2005 ·Environmental and Molecular Mutagenesis ·Mark Allegretta,(unknown),(unknown),(unknown),Franck Mortreux,Eric Wattel,(unknown)	4
7	Hypoxanthine-Guanine Phosphoribosyltransferase Reporter Gene Mutation for Analysis of in Vivo Clonal Amplification in Patients with HTLV Type 1-Associated Myelopathy/Tropical Spastic Paraparesis 2000 ·AIDS Research and Human Retroviruses ·Richard J. Albertini,(unknown),(unknown),Steven Jacobson,Mark Allegretta	7
8	Selection ofhprtMutant T Cells as Surrogates for Dividing Cells Reveals a Restricted T Cell Receptor BV Repertoire in Insulin-Dependent Diabetes Mellitus 1999 ·Clinical Immunology ·Michael T. Falta,(unknown),Mark Allegretta,Lawrence Steinman,Mark A. Atkinson,Steven W. Brostoff,R.J. Albertini	15
9	IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R α and γ chains 1999 ·Journal of Neuroimmunology ·Yuan K. Chou,Dennis Bourdette,David W. Barnes,(unknown),Susan Murray,(unknown),Ian Robey,Ruth H. Whitham,Abigail C. Buenafe,Mark Allegretta,Halina Offner,Arthur A. Vandenbark	20
10	Immunity to T Cell Receptor Peptides in Multiple Sclerosis. III. Preferential Immunogenicity of Complementarity-Determining Region 2 Peptides from Disease-Associated T Cell Receptor BV Genes 1998 ·The Journal of Immunology ·Dennis Bourdette,Yuan K. Chou,Ruth H. Whitham,Jane H. Buckner,(unknown),Gerald T. Nepom,Abigail C. Buenafe,(unknown),Mark Allegretta,George A. Hashim,Halina Offner,Arthur A. Vandenbark	20
11	Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein 1996 ·Nature ·Stefan Brocke,Koenraad Gijbels,Mark Allegretta,Iris Ferber,Christopher Piercy,(unknown),Roland Martinꝉ,Ursula Utz,Nathan Karin,Dennis J. Mitchell,Timo Veromaa,Ari Waisman,Amitabh Gaur,Paul Conlon,Nicholas Ling,Paul J. Fairchild,David C. Wraith,Anne O’Garra,C. Garrison Fathman,Lawrence Steinman	332
12	Unique T‐Cell Receptor Junctional Sequences Found in Multiple Sclerosis and T‐Cells Mediating Experimental Allergic Encephalomyelitis^a 1995 ·Annals of the New York Academy of Sciences ·Mark Allegretta,Lawrence Steinman	2
13	Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis. 1994 ·Journal of Clinical Investigation ·Mark Allegretta,Richard J. Albertini,Mark D. Howell,Larry Smith,Roland Martinꝉ,Henry F. McFarland,Subramaniam Sriram,Steven W. Brostoff,Lawrence Steinman	41
14	Myelin basic protein peptide specificity and T‐cell receptor gene usage of HPRT mutant T‐cell clones in patients with multiple sclerosis 1994 ·Annals of Neurology ·Patricia A. Lodge,Mark Allegretta,Lawrence Steinman,Subramaniam Sriram	21
15	The effect of T-lymphocyte ‘clonality’ on the calculated hprt mutation frequency occurring in vivo in humans 1994 ·Mutation Research/Environmental Mutagenesis and Related Subjects ·John P. O’Neill,Janice A. Nicklas,Timothy C. Hunter,(unknown),Mark Allegretta,Michael T. Falta,Richard F. Branda,Richard J. Albertini	38
16	Neoplastic and reactive human astrocytes express interleukin-8 gene 1992 ·Neurosurgical Review ·Taizo Nitta,Mark Allegretta,Ko Okumura,Kiyoshi Sato,Lawrence Steinman	33
17	Expression of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor genes in human astrocytoma cell lines and in glioma specimens 1992 ·Brain Research ·Taizo Nitta,Kiyoshi Sato,Mark Allegretta,Stefan Brocke,(unknown),Dennis J. Mitchell,Lawrence Steinman	51
18	T Cells Responsive to Myelin Basic Protein in Patients with Multiple Sclerosis 1990 ·Science ·Mark Allegretta,Janice A. Nicklas,Subramaniam Sriram,Richard J. Albertini	370
19	Molecular analyses of in vivo hypoxanthine‐guanine phosphoribosyltransferase mutations in human T‐lymphocytes: II. Demonstration of a clonal amplification of hprt mutant T‐lymphocytes in vivo 1988 ·Environmental Mutagenesis ·Janice A. Nicklas,John P. O’Neill,Lisa Sullivan,Tim Hunter,Mark Allegretta,(unknown),Bisharah L. Libbus,Richard J. Albertini	60
20	Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease. 1986 ·Journal of Clinical Oncology ·Michael B. Atkins,(unknown),Mark Allegretta,(unknown),Roy A. Dempsey,Richard A. Rudders,David Parkinson,Seymour Reichlin,J W Mier	121

About Mark Allegretta

Mark Allegretta is a scholar working on Immunology, Hepatology and Immunology and Allergy, having authored 32 papers that have together received 1.9k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (7 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Immunology (986 citations), Hepatology (198 citations) and Pathology and Forensic Medicine (377 citations). Mark Allegretta has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Richard J. Albertini, Janice A. Nicklas, Subramaniam Sriram, Roy A. Dempsey, Lawrence Steinman, David Parkinson, Stefan Brocke, Dennis J. Mitchell, Ronald D. Guttmann and Roland Martinꝉ. Their work appears in journals such as Nature, Science and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact